The expression of SSH1, CLOCK, BMAL1 and β-catenin proteins were significantly downregulated in the Sennoside Adark treat mice (Figure 5), indicating that the oncogenic activity of SSH1 has a circadian rhythm molecular underlining and that this can be exploited for the therapeutic benefit of patients with HCC. This evidence concerns the gene SSH1 and hepatocellular carcinoma.